Bicycle Therapeutics plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCYC | CGEN | ONCO.ST | CHRS | CCCC | HBP.TO | |
|---|---|---|---|---|---|---|
| Market cap | 260.75M | 192.29M | 767.39M | 131.36M | 383.84M | 70.27M |
| P/E (TTM) | — | 5.3 | — | — | — | — |
| Forward P/E | -1.6 | -5.5 | -2.5 | -1.3 | -3.4 | -8.4 |
| Price/book | 0.5 | 2.2 | 28.2 | 2.2 | 1.6 | 4.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −40.52% | +22.56% | −66.03% | −48.50% | +35.44% | −54.00% |
| Today | +1.36% | +1.00% | +3.19% | +5.54% | −2.80% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCYC news ›Bicycle Therapeutics (NASDAQ:BCYC) Issues Quarterly Earnings Results
Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) released its earnings results on Thursday. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.25, FiscalAI reports.…
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
Nuzefatide pevedotin granted FDA Orphan Drug Designation for the treatment of pancreatic cancer; further updates expected in 2027 Initiation of the first company-sponsored radioligand clinical trial for BT1702, an MT1-MMP targeting…
Bicycle Therapeutics GAAP EPS of -$0.15 beats by $0.33, revenue of $34.06M beats by $21.86M
Bicycle Therapeutics Q3 results beat on EPS and revenue, with sales up 190% year over year. - Bicycle Therapeutics press release (BCYC): Q3 GAAP EPS of -$0.15 beats by $0.33. - Revenue of $34.06M (+190.4% Y/Y) beats by $21.86M. More on…
Cycling Accessories Maker Feedback Sports Hires Americas Sales Manager
Feedback Sports, a manufacturer of premium bicycle repair stands, tools, trainers, and storage solutions, appointed Michael Kowalski as sales manager of the Americas. Kowalski brings 15 years of experience in sales in the cycling space,…
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP). In a report released today, Brendan Smith from TD Cowen maintained a…
Sportradar legal chief Miller sells 1,840 shares
Under a trading plan, Sportradar (SRAD) legal chief sells 1,840 shares. Stock Titan - [Form 4] Sportradar Group AG Insider Trading Activity Sportradar legal chief Miller sells 1,840 shares The sale was made under a Rule 10b5-1 trading plan…
eHealth director Soistman proposes $14.1K share sale
eHealth, Inc. (EHTH) is a private online health insurance marketplace and licensed agency, focused on Medicare and individual coverage through U.S. carriers. eHealth director Soistman proposes $14.1K share sale His notice also lists sales…
Bicycle Therapeutics officer plans 9,000-share sale
Bicycle Therapeutics plc (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing Bicycle® molecules, BDCs and radioconjugates for oncology. Bicycle Therapeutics officer plans 9,000-share sale Kevin Lee also reported a sale…
Bicycle Therapeutics CFO Travis Thompson Executes 972-Share RSU Tax Withholding Sales
Can SRS and GMS Sharpen Home Depot's (NYSE:HD) Pro Strategy? Why Is Target Corporation (NYSE:TGT) Lifting Its Sales Growth View? On October 6, 2026, Travis Alvin Thompson, Chief Financial Officer of Bicycle Therapeutics PLC (NASDAQ:BCYC)…
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC) Receives Consensus Rating of “Hold” from Brokerages
Posted by Michael Walen on Oct 4th, 2026 Get Our Latest Analysis on BCYC Shares of NASDAQ BCYC opened at $3.38 on Friday. The stock’s 50-day moving average is $3.96 and its 200 day moving average is $4.32. The stock has a market cap of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net10
- seekingalpha.com2
- kalkinemedia.com1
- markets.businessinsider.com1
- sgbonline.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.